Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2012, Article ID 146154, 12 pages
http://dx.doi.org/10.1155/2012/146154
Review Article

Inflammation in Diabetic Nephropathy

1Department of Nephrology, Monash Medical Centre, 246 Clayton Road, Clayton, VIC 3168, Australia
2Monash University Department of Medicine, Monash Medical Centre, 246 Clayton Road, Clayton, VIC 3168, Australia

Received 24 May 2012; Accepted 5 July 2012

Academic Editor: Oreste Gualillo

Copyright © 2012 Andy K. H. Lim and Gregory H. Tesch. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [162 citations]

The following is the list of published articles that have cited the current article.

  • Alan D. Salama, “Diabetic Nephropathy,” Nephrology Times, vol. 5, no. 11, pp. 10–11, 2012. View at Publisher · View at Google Scholar
  • Dung V. Nguyen, Lynn C. Shaw, and Maria B. Grant, “Inflammation in the pathogenesis of microvascular complications in diabetes,” Frontiers in Endocrinology, vol. 3, 2012. View at Publisher · View at Google Scholar
  • Xiaodong Ma, Jingjing Ding, Haiyan Min, Yanting Wen, and Qian Gao, “Protective role of low-dose TGF-β1 in early diabetic nephropathy induced by streptozotocin,” International Immunopharmacology, 2013. View at Publisher · View at Google Scholar
  • Aaron D. McClelland, and Phillip Kantharidis, “microRNA in the development of diabetic complications,” Clinical Science, vol. 126, no. 2, pp. 95–110, 2013. View at Publisher · View at Google Scholar
  • Jacobien C. Verhave, Josée Bouchard, Rémi Goupil, Vincent Pichette, Soumeya Brachemi, François Madore, and Stéphan Troyanov, “Clinical value of inflammatory urinary biomarkers in overt diabetic nephropathy: A prospective study,” Diabetes Research and Clinical Practice, 2013. View at Publisher · View at Google Scholar
  • Devadass Clement Wilfred, Vijaya Viswanath Mysorekar, Raju S Venkataramana, Mahesh Eshwarappa, and Revathi Subramanyan, “Nondiabetic Renal Disease in type 2 Diabetes Mellitus Patients: A Clinicopathological Study.,” Journal of laboratory physicians, vol. 5, no. 2, pp. 94–9, 2013. View at Publisher · View at Google Scholar
  • Gabriela Campanholle, Giovanni Ligresti, Sina A Gharib, and Jeremy S Duffield, “Cellular mechanisms of tissue fibrosis. 3. Novel mechanisms of kidney fibrosis.,” American journal of physiology. Cell physiology, vol. 304, no. 7, 2013. View at Publisher · View at Google Scholar
  • Michelle HT Ta, David CH Harris, and Gopala K Rangan, “Role of interstitial inflammation in the pathogenesis of polycystic kidney disease,” Nephrology, vol. 18, no. 5, pp. 317–330, 2013. View at Publisher · View at Google Scholar
  • Pengchao Du, Baoxia Fan, Huirong Han, Junhui Zhen, Jin Shang, Xiaojie Wang, Xiang Li, Weichen Shi, Wei Tang, Chanchan Bao, Ziying Wang, Yan Zhang, Bin Zhang, Xinbing Wei, and Fan Yi, “NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy,” Kidney International, 2013. View at Publisher · View at Google Scholar
  • Ying Liu, Zhanjun Jia, Shanshan Liu, Maicy Downton, Gang Liu, Yaomin Du, and Tianxin Yang, “Combined losartan and nitro-oleic acid remarkably improves diabetic nephropathy in mice,” American Journal of Physiology-Renal Physiology, vol. 305, no. 11, pp. F1555–F1562, 2013. View at Publisher · View at Google Scholar
  • Jian Wu, Yaqing Ding, Chunling Zhu, Xiaohong Shao, Xin Xie, Kan Lu, and Rui Wang, “Urinary TNF-alpha and NGAL are correlated with the progression of nephropathy in patients with type 2 diabetes,” Experimental and Therapeutic Medicine, vol. 6, no. 6, pp. 1482–1488, 2013. View at Publisher · View at Google Scholar
  • Hiroshi Okada, Michiaki Fukui, Muhei Tanaka, Shinobu Matsumoto, Kanae Kobayashi, Hiroya Iwase, Kiichiro Tomiyasu, Koji Nakano, Goji Hasegawa, and Naoto Nakamura, “Low serum bilirubin concentration is a novel risk factor for the development of albuminuria in patients with type 2 diabetes,” Metabolism, 2013. View at Publisher · View at Google Scholar
  • Siddesh Jaiman, Arun Kumar Sharma, Kulwant Singh, and Deepa Khanna, “Signalling mechanisms involved in renal pathological changes during cisplatin-induced nephropathy,” European Journal of Clinical Pharmacology, vol. 69, no. 11, pp. 1863–1874, 2013. View at Publisher · View at Google Scholar
  • A. Hashikata, A. Yamashita, S. Suzuki, S. Nagayasu, T. Shinjo, A. Taniguchi, M. Fukushima, Y. Nakai, K. Nin, N. Watanabe, T. Asano, Y. Abiko, A. Kushiyama, S. Nagasaka, and F. Nishimura, “The inflammation-lipocalin 2 axis may contribute to the development of chronic kidney disease,” Nephrology Dialysis Transplantation, 2013. View at Publisher · View at Google Scholar
  • Haojun Zhang, Tingting Zhao, Yuewen Gong, Xi Dong, Weiku Zhang, Sifan Sun, Hua Wang, Yanting Gu, Xiaoguang Lu, Meihua Yan, and Ping Li, “Attenuation of diabetic nephropathy by Chaihuang-Yishen Granule through anti-inflammatory mechanism in streptozotocin-induced rat model of diabetics,” Journal of Ethnopharmacology, 2013. View at Publisher · View at Google Scholar
  • Thing-Fong Tzeng, Shorong-Shii Liou, Chia Ju Chang, and I-Min Liu, “Zerumbone, a tropical ginger sesquiterpene, ameliorates streptozotocin-induced diabetic nephropathy in rats by reducing the hyperglycemia-induced inflammatory response,” Nutrition & Metabolism, vol. 10, 2013. View at Publisher · View at Google Scholar
  • Hung-Jen Lu, Thing-Fong Tzeng, Jui-Chin Hsu, Shih-Hao Kuo, Chia-Hsin Chang, Shin-Ya Huang, Fang-Yu Chang, Ming-Chang Wu, and I-Min Liu, “An aqueous-ethanol extract of liriope spicata var. Prolifera ameliorates diabetic nephropathy through suppression of renal inflammation,” Evidence-based Complementary and Alternative Medicine, vol. 2013, 2013. View at Publisher · View at Google Scholar
  • Jia-sheng Wu, Rong Shi, Jie Zhong, Xiong Lu, Bing-liang Ma, Tian-ming Wang, Bin Zan, Yue-ming Ma, Neng-neng Cheng, and Fu-rong Qiu, “Renal Protective Role of Xiexin Decoction with Multiple Active Ingredients Involves Inhibition of Inflammation through Downregulation of the Nuclear Factor-B Pathway in Diabetic Rats,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, pp. 1–15, 2013. View at Publisher · View at Google Scholar
  • Wencheng Jian, Xiumei Zhang, Fan Yi, Xiang Li, Fengli Li, Yongli Chu, Xiaojie Wang, Hongyu Zhang, Yanyan Hu, Yan Zhang, Ziying Wang, and Xinbing Wei, “NOD2 Deficiency Protects against Cardiac Remodeling after Myocardial Infarction in Mice,” Cellular Physiology and Biochemistry, vol. 32, no. 6, pp. 1857–1866, 2013. View at Publisher · View at Google Scholar
  • Kayte A. Jenkin, Andrew J. McAinch, Jessica F. Briffa, Yuan Zhang, Darren J. Kelly, Carol A. Pollock, Philip Poronnik, and Deanne H. Hryciw, “Cannabinoid Receptor 2 Expression in Human Proximal Tubule Cells is Regulated by Albumin Independent of ERK1/2 Signaling,” Cellular Physiology and Biochemistry, vol. 32, no. 5, pp. 1309–1319, 2013. View at Publisher · View at Google Scholar
  • Stefan Pscherer, Thomas Forst, Karl F. Braun, Andreas K. Nussler, Sabrina Ehnert, and Thomas Freude, “Anti-diabetic treatment regulates pro-fibrotic TGF-beta serum levels in type 2 diabetics,” Diabetology & Metabolic Syndrome, vol. 5, 2013. View at Publisher · View at Google Scholar
  • Elyse Di Marco, Stephen P. Gray, and Karin Jandeleit-Dahm, “Diabetes alters activation and repression of pro- and anti-inflammatory signaling pathways in the vasculature,” Frontiers in Endocrinology, vol. 4, 2013. View at Publisher · View at Google Scholar
  • Masako Furukawa, Tomohito Gohda, Mitsuo Tanimoto, and Yasuhiko Tomino, “Pathogenesis and Novel Treatment from the Mouse Model of Type 2 Diabetic Nephropathy,” The Scientific World Journal, vol. 2013, pp. 1–8, 2013. View at Publisher · View at Google Scholar
  • Jacqueline R. Dauch, Brandon M. Yanik, Hsinlin T. Cheng, Lucia A. Luna-Wong, Diane E. Bender, Wilson Hsieh, and Zachary A. Kelly, “Neurogenic factor-induced Langerhans cell activation in diabetic mice with mechanical allodynia,” Journal Of Neuroinflammation, vol. 10, 2013. View at Publisher · View at Google Scholar
  • Keizo Kanasaki, Gangadhar Taduri, and Daisuke Koya, “Diabetic nephropathy: The role of inflammation in fibroblast activation and kidney fibrosis,” Frontiers in Endocrinology, vol. 4, 2013. View at Publisher · View at Google Scholar
  • Yiping Wang, and David C. H. Harris, “Pathogenic and protective role of macrophages in kidney disease,” American Journal Of Physiology-Renal Physiology, vol. 305, no. 1, pp. F3–F11, 2013. View at Publisher · View at Google Scholar
  • Song Zhang, Shu-Shen Zheng, Lin Zhu, and Jun Hao, “Effect of increased serum TNF-α on lipid accumulation in kidney of diabetes,” Chinese Pharmacological Bulletin, vol. 30, no. 8, pp. 1161–1165, 2014. View at Publisher · View at Google Scholar
  • Jy Zhao Junyu, Jj Dong Jianjun, Hp Wang Haipeng, Hx Shang Hongxia, Dm Zhang Dongmei, and L Liao Lin, “Efficacy and safety of vitamin D-3 in patients with diabetic nephropathy: a meta-analysis of randomized controlled trials,” Chinese Medical Journal, vol. 127, no. 15, pp. 2837–2843, 2014. View at Publisher · View at Google Scholar
  • Yan-Ni Cao, Shen-Yin Zhu, Yuan-Da Zhou, Juan Li, Xiao-Ying Zheng, and Jie Dong, “Amelioration of diabetic nephropathy in rats by resveratrol: involvement of anti-inflammatory effect,” Chinese Pharmaceutical Journal, vol. 49, no. 11, pp. 919–924, 2014. View at Publisher · View at Google Scholar
  • Chunling Huang, Carol A. Pollock, and Xin‑Ming Chen, “ Role of the potassium channel K Ca 3.1 in diabetic nephropathy ,” Clinical Science, vol. 127, no. 7, pp. 423–433, 2014. View at Publisher · View at Google Scholar
  • Xing-xin Xu, Xiang-Ming Qi, Wei Zhang, Chao-Qun Zhang, Xiao-Xu Wu, Yong-Gui Wu, Kun Wang, and Ji-Jia Shen, “Effects of total glucosides of paeony on immune regulatory toll-like receptors TLR2 and 4 in the kidney from diabetic rats,” Phytomedicine, vol. 21, no. 6, pp. 815–823, 2014. View at Publisher · View at Google Scholar
  • Yuehong Zhou, Chuan Lv, Can Wu, Fenqin Chen, Ying Shao, and Qiuyue Wang, “Suppressor of cytokine signaling (SOCS) 2 attenuates renal lesions in rats with diabetic nephropathy,” Acta Histochemica, 2014. View at Publisher · View at Google Scholar
  • Stephen P. Gray, and Karin Jandeleit-Dahm, “The pathobiology of diabetic vascular complications—cardiovascular and kidney disease,” Journal of Molecular Medicine, 2014. View at Publisher · View at Google Scholar
  • Hung-Jen Lu, Thing-Fong Tzeng, Shorong-Shii Liou, Sheng Da Lin, Ming-Chang Wu, and I-Min Liu, “Ruscogenin ameliorates diabetic nephropathy by its anti-inflammatory and anti-fibrotic effects in streptozotocin-induced diabetic rat,” Bmc Complementary and Alternative Medicine, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Sian P. Cartland, Jonathan H. Erlich, and Mary M. Kavurma, “TRAIL Deficiency Contributes to Diabetic Nephropathy in Fat-Fed ApoE(-/-) Mice,” Plos One, vol. 9, no. 3, 2014. View at Publisher · View at Google Scholar
  • Irene Vinagre, Jose Luis Sanchez-Quesada, Juan Sanchez-Hernandez, David Santos, Jordi Ordonez-Llanos, Alberto De Leiva, and Antonio Perez, “Inflammatory biomarkers in type 2 diabetic patients: effect of glycemic control and impact of ldl subfraction phenotype,” Cardiovascular Diabetology, vol. 13, 2014. View at Publisher · View at Google Scholar
  • Qingjuan Liu, Lingling Xing, Lei Wang, Fang Yao, Shuxia Liu, Jun Hao, Wei Liu, and Huijun Duan, “Therapeutic Effects of Suppressors of Cytokine Signaling in Diabetic Nephropathy,” Journal of Histochemistry & Cytochemistry, vol. 62, no. 2, pp. 119–128, 2014. View at Publisher · View at Google Scholar
  • Derek P. DiRocco, John Bisi, Patrick Roberts, Jay Strum, Kwok-Kin Wong, Norman Sharpless, and Benjamin D. Humphreys, “CDK4/6 inhibition induces epithelial cell cycle arrest and ameliorates acute kidney injury,” American Journal of Physiology-Renal Physiology, vol. 306, no. 4, pp. F379–F388, 2014. View at Publisher · View at Google Scholar
  • Madalina V. Nastase, Renato V. Iozzo, and Liliana Schaefer, “Key roles for the small leucine-rich proteoglycans in renal and pulmonary pathophysiology,” Biochimica et Biophysica Acta (BBA) - General Subjects, 2014. View at Publisher · View at Google Scholar
  • Francesca D'Addio, Alessio Trevisani, Moufida Ben Nasr, Roberto Bassi, Basset El Essawy, Reza Abdi, Antonio Secchi, and Paolo Fiorina, “Harnessing the immunological properties of stem cells as a therapeutic option for diabetic nephropathy,” Acta Diabetologica, vol. 51, no. 6, pp. 897–904, 2014. View at Publisher · View at Google Scholar
  • Mojca Urbancic, Spela Stunf, Aleksandra Milutinovic Zivin, Daniel Petrovic, and Mojca Globocnik Petrovic, “Epiretinal Membrane Inflammatory Cell Density Might Reflect the Activity of Proliferative Diabetic Retinopathy,” Investigative Ophthalmology & Visual Science, vol. 55, no. 12, pp. 8576–8582, 2014. View at Publisher · View at Google Scholar
  • Rachel Goldberg, Ariel M. Rubinstein, Natali Gil, Esther Hermano, Jin-Ping Li, Johan van der Vlag, Ruth Atzmon, Amichay Meirovitz, and Michael Elkin, “Role of Heparanase-Driven Inflammatory Cascade in Pathogenesis of Diabetic Nephropathy,” Diabetes, vol. 63, no. 12, pp. 4302–4313, 2014. View at Publisher · View at Google Scholar
  • Marcela Abbott Galvão Ururahy, Karla Simone Costa de Souza, Yonara Monique da Costa Oliveira, Melina Bezerra Loureiro, Heglayne Pereira Vital da Silva, Francisco Paulo Freire-Neto, João Felipe Bezerra, André Ducati Luchessi, Sonia Quateli Doi, Rosario Dominguez Crespo Hirata, Maria das Graças Almeida, Ricardo Fernando Arrais, Mario Hiroyuki Hirata, and Adriana Augusto de Rezende, “ Association of polymorphisms in IL6 gene promoter region with type 1 diabetes and increased albumin-to-creatinine ratio ,” Diabetes/Metabolism Research and Reviews, 2014. View at Publisher · View at Google Scholar
  • Wilfred A Nix, Rudolf Zirwes, Volkhard Bangert, Raimund Peter Kaiser, Matthias Schilling, Ulrike Hostalek, and Rima Obeid, “Vitamin B status in patients with type 2 diabetes mellitus with and without incipient nephropathy,” Diabetes Research and Clinical Practice, 2014. View at Publisher · View at Google Scholar
  • Xiang Zhou, Yu Feng, Zhoubing Zhan, and Jianchang Chen, “Hydrogen Sulfide Alleviates Diabetic Nephropathy in a Streptozotocin-induced Diabetic Rat Model,” Journal of Biological Chemistry, vol. 289, no. 42, pp. 28827–28834, 2014. View at Publisher · View at Google Scholar
  • Andy K. H. Lim, Andy K. H. Lim, and Andy K. H. Lim, “Diabetic nephropathy – Complications and treatment,” International Journal of Nephrology and Renovascular Disease, vol. 7, pp. 361–381, 2014. View at Publisher · View at Google Scholar
  • Yong Li, Lei Bao, Zhaofeng Zhang, Xiaoqian Dai, Ye Ding, Yanfei Jiang, and Yujie Li, “Effects of grape seed proanthocyanidin extract on renal injury in type 2 diabetic rats,” Molecular Medicine Reports, vol. 11, no. 1, pp. 645–652, 2014. View at Publisher · View at Google Scholar
  • Yasunori Iwata, Kengo Furuichi, Shinichi Hashimoto, Kiyonobu Yokota, Haruka Yasuda, Norihiko Sakai, Shinji Kitajima, Tadashi Toyama, Yasuyuki Shinozaki, Akihiro Sagara, Kouji Matsushima, Shuichi Kaneko, and Takashi Wada, “Pro-inflammatory/Th1 gene expression shift in high glucose stimulated mesangial cells and tubular epithelial cells,” Biochemical and Biophysical Research Communications, vol. 443, no. 3, pp. 969–974, 2014. View at Publisher · View at Google Scholar
  • Shreesh Ojha, Juma Alkaabi, Naheed Amir, Azimullah Sheikh, Ahmad Agil, Mohamed Abdelmonem Fahim, and Abdu Adem, “ Withania coagulans Fruit Extract Reduces Oxidative Stress and Inflammation in Kidneys of Streptozotocin-Induced Diabetic Rats ,” Oxidative Medicine and Cellular Longevity, vol. 2014, pp. 1–9, 2014. View at Publisher · View at Google Scholar
  • Monika Ryba-Stanisławowska, Karolina Rybarczyk-Kapturska, Agnieszka Brandt, Małgorzata Myśliwiec, and Jolanta Myśliwska, “IVS1 −397T>C Estrogen Receptor α Polymorphism Is Associated with Low-Grade Systemic Inflammatory Response in Type 1 Diabetic Girls,” Mediators of Inflammation, vol. 2014, pp. 1–8, 2014. View at Publisher · View at Google Scholar
  • Qi Wu, Huan Yang, and Jian-Xin Yu, “Correlation between type 1 diabetic nephropathy and insulin resistance,” World Chinese Journal of Digestology, vol. 22, no. 26, pp. 3925–3931, 2014. View at Publisher · View at Google Scholar
  • Yanyan Yang, Seung Cheol Kim, Tao Yu, Young-Su Yi, Man Hee Rhee, Gi-Ho Sung, Byong Chul Yoo, and Jae Youl Cho, “Functional Roles of p38 Mitogen-Activated Protein Kinase in Macrophage-Mediated Inflammatory Responses,” Mediators of Inflammation, vol. 2014, pp. 1–13, 2014. View at Publisher · View at Google Scholar
  • Yang Zhang, Jing Liu, Yu Wu, Ze Bo Hu, Xiong Zhong Ruan, and Bi Cheng Liu, “Establishment of an Inflamed Animal Model of Diabetic Nephropathy,” International Journal of Biological Sciences, vol. 10, no. 2, pp. 149–159, 2014. View at Publisher · View at Google Scholar
  • Catarina Marques, Cristina Mega, Andreia Gonçalves, Paulo Rodrigues-Santos, Edite Teixeira-Lemos, Frederico Teixeira, Carlos Fontes-Ribeiro, Flávio Reis, and Rosa Fernandes, “Sitagliptin Prevents Inflammation and Apoptotic Cell Death in the Kidney of Type 2 Diabetic Animals,” Mediators of Inflammation, vol. 2014, pp. 1–15, 2014. View at Publisher · View at Google Scholar
  • Abeer A. Al-Refai, Safaa I. Tayel, Ahmed Ragheb, Ashraf G. Dala, and Ahmed Zahran, “Urinary Neutrophil Gelatinase Associated Lipocalin as a Marker of Tubular Damage in Type 2 Diabetic Patients with and without Albuminuria,” Open Journal of Nephrology, vol. 04, no. 01, pp. 37–46, 2014. View at Publisher · View at Google Scholar
  • Chao-Qun Zhang, Xiao-Xu Wu, Yong-Gui Wu, Xing-Xin Xu, Wei Zhnag, and Kun Wang, “Effect of total glucosides of paeony on TLR signal pathway in the kidney from diabetic rats,” Chinese Pharmacological Bulletin, vol. 30, no. 3, pp. 354–359, 2014. View at Publisher · View at Google Scholar
  • Amjid Ahad, Haseeb Ahsan, Mohd. Mujeeb, and Waseem Ahmad Siddiqui, “Gallic acid ameliorates renal functions by inhibiting the activation of p38 MAPK in experimentally induced type 2 diabetic rats and cultured rat proximal tubular epithelial cells,” Chemico-Biological Interactions, 2015. View at Publisher · View at Google Scholar
  • Serdar Kahvecioglu, Metin Guclu, Yasemin Ustundag, Cuma Bulent Gul, Ibrahim Dogan, Tuncay Dagel, Bennur Esen, Selin Akturk Esen, Huseyin Celik, and Irfan Esen, “Evaluation of serum Spondin 2 levels in the different stages of Type 2 diabetic nephropathy,” Nephrology, vol. 20, no. 10, pp. 721–726, 2015. View at Publisher · View at Google Scholar
  • Merlin C. Thomas, Michael Brownlee, Katalin Susztak, Kumar Sharma, Karin A. M. Jandeleit-Dahm, Sophia Zoungas, Peter Rossing, Per-Henrik Groop, and Mark E. Cooper, “Diabetic kidney disease,” Nature Reviews Disease Primers, pp. 15018, 2015. View at Publisher · View at Google Scholar
  • A. Almeida, O. Lourenço, and A. M. Fonseca, “Haemodialysis in Diabetic Patients Modulates Inflammatory Cytokine Profile and T Cell Activation Status,” Scandinavian Journal of Immunology, vol. 82, no. 2, pp. 135–141, 2015. View at Publisher · View at Google Scholar
  • Yang Yang, Gang Chen, Xiaolan Cheng, Zhiying Teng, Xueting Cai, Jie Yang, Xiaoyan Sun, Wuguang Lu, Xiaoning Wang, Yuanzhang Yao, Chunping Hu, and Peng Cao, “Therapeutic potential of digitoflavone on diabetic nephropathy: nuclear factor erythroid 2-related factor 2-dependent anti-oxidant and anti-inflammato,” Scientific Reports, vol. 5, 2015. View at Publisher · View at Google Scholar
  • Cheng-Xi Jiang, Liang-Yi Lin, Jiao Song, Jin-Guo Cheng, Qiao-Qiao Zhang, Fan He, and Ya-Li Zhang, “Alleviation of curcumin analog WZ35 on type 1 diabetes-induced renal injury via inhibiting inflammatory response,” Chinese Traditional and Herbal Drugs, vol. 46, no. 12, pp. 1785–1790, 2015. View at Publisher · View at Google Scholar
  • Si-Fan Sun, Ting-Ting Zhao, Hao-Jun Zhang, Xiao-Ru Huang, Wei-Ku Zhang, Lei Zhang, Mei-Hua Yan, Xi Dong, Hua Wang, Yu-Min Wen, Xin-Ping Pan, Hui Yao Lan, and Ping Li, “Renoprotective effect of berberine on type 2 diabetic nephropathy in rats,” Clinical and Experimental Pharmacology and Physiology, vol. 42, no. 6, pp. 662–670, 2015. View at Publisher · View at Google Scholar
  • Ying Luo, Shi-kun Yang, Xun Zhou, Ming Wang, Dan Tang, Fu-you Liu, Lin Sun, and Li Xiao, “ Use of Ophiocordyceps sinensis (syn. Cordyceps sinensis ) combined with angiotensin-converting enzyme inhibitors (ACEI)/angiotensin receptor blockers (ARB) versus ACEI/ARB alone in the treatment of diabetic kidney disease: a meta-analysis ,” Renal Failure, vol. 37, no. 4, pp. 614–634, 2015. View at Publisher · View at Google Scholar
  • Subhashini Bolisetty, Abolfazl Zarjou, Travis D Hull, Amie M Traylor, Anjana Perianayagam, Reny Joseph, Ahmed I Kamal, Paolo Arosio, Miguel P Soares, Viktoria Jeney, Jozsef Balla, James F George, and Anupam Agarwal, “Macrophage and epithelial cell H-ferritin expression regulates renal inflammation,” Kidney International, 2015. View at Publisher · View at Google Scholar
  • Kayte A Jenkin, Andrew J McAinch, Yuan Zhang, Darren J Kelly, and Deanne H Hryciw, “Elevated cannabinoid receptor 1 and G protein-coupled receptor 55 expression in proximal tubule cells and whole kidney exposed to diabetic conditions,” Clinical and Experimental Pharmacology and Physiology, vol. 42, no. 3, pp. 256–262, 2015. View at Publisher · View at Google Scholar
  • Malvin N. Janal, Juan Crosby, Robert Donnelly, and Monique S. Roy, “Markers of endothelial dysfunction and inflammation predict progression of diabetic nephropathy in African Americans with type 1 diabetes,” Kidney International, vol. 87, no. 2, pp. 427–433, 2015. View at Publisher · View at Google Scholar
  • Yang Zhang, Kun Ling Ma, Jing Liu, Yu Wu, Ze Bo Hu, Liang Liu, Jian Lu, Xiao Liang Zhang, and Bi Cheng Liu, “Inflammatory stress exacerbates lipid accumulation and podocyte injuries in diabetic nephropathy,” Acta Diabetologica, vol. 52, no. 6, pp. 1045–1056, 2015. View at Publisher · View at Google Scholar
  • K. Bhatt, L. L. Lanting, Y. Jia, S. Yadav, M. A. Reddy, N. Magilnick, M. Boldin, and R. Natarajan, “Anti-Inflammatory Role of MicroRNA-146a in the Pathogenesis of Diabetic Nephropathy,” Journal of the American Society of Nephrology, vol. 27, no. 8, pp. 2277–2288, 2015. View at Publisher · View at Google Scholar
  • Sameh Abouzeid, and Nevine Sherif, “Role of alteration in Treg/Th17 cells' balance in nephropathic patients with Type 2 diabetes mellitus.,” Electronic physician, vol. 7, no. 8, pp. 1613–8, 2015. View at Publisher · View at Google Scholar
  • Md. Ashraful Alam, Mohammed Riaz Hasan Chowdhury, Preeti Jain, Md. Abu Taher Sagor, and Hasan Mahmud Reza, “DPP-4 inhibitor sitagliptin prevents inflammation and oxidative stress of heart and kidney in two kidney and one clip (2K1C) rats,” Diabetology & Metabolic Syndrome, vol. 7, no. 1, 2015. View at Publisher · View at Google Scholar
  • Yong-Liang Yuan, Chang-Run Guo, Ling-Ling Cui, Shi-Xia Ruan, Chun-Feng Zhang, De Ji, Zhong-Lin Yang, and Fei Li, “Timosaponin B-II ameliorates diabetic nephropathy via TXNIP, mTOR, and NF-κB signaling pathways in alloxan-induced mice,” Drug Design, Development and Therapy, vol. 9, pp. 6247–6258, 2015. View at Publisher · View at Google Scholar
  • Cunjie Li, and Ting Lei, “Rs12976445 polymorphism is associated with risk of diabetic nephropathy through modulating expression of microRNA-125 and interleukin-6R,” Medical Science Monitor, vol. 21, pp. 3490–3497, 2015. View at Publisher · View at Google Scholar
  • Lin Sun, and Yashpal S. Kanwar, “Relevance of TNF-alpha in the context of other inflammatory cytokines in the progression of diabetic nephropathy,” Kidney International, vol. 88, no. 4, pp. 662–665, 2015. View at Publisher · View at Google Scholar
  • Suomi M. G. Fouraschen, Joshua H. Wolf, Luc J. W. van der Laan, Petra E. de Ruiter, Wayne W. Hancock, Job P. van Kooten, Monique M. A. Verstegen, Kim M. Olthoff, and Jeroen de Jonge, “Mesenchymal Stromal Cell-Derived Factors Promote Tissue Repair in a Small-for-Size Ischemic Liver Model but Do Not Protect against Early Effects of Is,” Journal Of Immunology Research, 2015. View at Publisher · View at Google Scholar
  • Fernando H. G. Tessaro, Thais S. Ayala, and Joilson O. Martins, “Lipid Mediators Are Critical in Resolving Inflammation: A Review of the Emerging Roles of Eicosanoids in Diabetes Mellitus,” BioMed Research International, vol. 2015, pp. 1–8, 2015. View at Publisher · View at Google Scholar
  • Gina Manda, Alexandru-Ionel Checherita, Maria Victoria Comanescu, and Mihail Eugen Hinescu, “Redox Signaling in Diabetic Nephropathy: Hypertrophy versus Death Choices in Mesangial Cells and Podocytes,” Mediators of Inflammation, vol. 2015, pp. 1–13, 2015. View at Publisher · View at Google Scholar
  • Yan Zhao, Si-jia Chen, Jian-cheng Wang, Hong-xin Niu, Qian-qian Jia, Xiao-wen Chen, Xiao-yan Du, Lu Lu, Bo Huang, Quan Zhang, Yue Chen, and Hai-bo Long, “ Sesquiterpene Lactones Inhibit Advanced Oxidation Protein Product-Induced MCP-1 Expression in Podocytes via an IKK/NF- κ B-Dependent Mechanism ,” Oxidative Medicine and Cellular Longevity, vol. 2015, pp. 1–13, 2015. View at Publisher · View at Google Scholar
  • Ze-jun Ma, Xiao-na Zhang, Li Li, Wei Yang, Shan-shan Wang, Xin Guo, Pei Sun, and Li-ming Chen, “Tripterygium Glycosides Tablet Ameliorates Renal Tubulointerstitial Fibrosis via the Toll-Like Receptor 4/Nuclear Factor Kappa B Signaling Pathway in High-Fat Diet Fed and Streptozotocin-Induced Diabetic Rats,” Journal of Diabetes Research, vol. 2015, pp. 1–10, 2015. View at Publisher · View at Google Scholar
  • David K. Packham, Ian R. Fraser, Peter G. Kerr, and Karen R. Segal, “Allogeneic Mesenchymal Precursor Cells (MPC) in Diabetic Nephropathy: A Randomized, Placebo-controlled, Dose Escalation Study,” EBioMedicine, 2016. View at Publisher · View at Google Scholar
  • Xiaolei Hu, Xiaomei Zhang, Guoxi Jin, Zhaoming Shi, Weihua Sun, and Fengling Chen, “Geniposide reduces development of streptozotocin-induced diabetic nephropathy via regulating nuclear factor-kappa B signaling pathways,” Fundamental & Clinical Pharmacology, 2016. View at Publisher · View at Google Scholar
  • Zhikui Wang, Zhaoxia Wang, Zhongqi Zhou, and Yueqin Ren, “Crucial genes associated with diabetic nephropathy explored by microarray analysis,” BMC Nephrology, vol. 17, no. 1, 2016. View at Publisher · View at Google Scholar
  • Yingjie Xu, Quanbin Zhang, Dali Luo, Jing Wang, and Delin Duan, “Low molecular weight fucoidan ameliorates the inflammation and glomerular filtration function of diabetic nephropathy,” Journal of Applied Phycology, 2016. View at Publisher · View at Google Scholar
  • Linhao Xu, Peiqiang Shen, Yanli Bi, Jian Chen, Zhangang Xiao, Xiaoming Zhang, and Zheng Wang, “Danshen injection ameliorates STZ-induced diabetic nephropathy in association with suppression of oxidative stress, pro-inflammatory factors and fibrosis,” International Immunopharmacology, vol. 38, pp. 385–394, 2016. View at Publisher · View at Google Scholar
  • Reza Meshkani, and Sanaz Vakili, “Tissue resident macrophages: Key players in the pathogenesis of type 2 diabetes and its complications,” Clinica Chimica Acta, 2016. View at Publisher · View at Google Scholar
  • John D. Short, Kevin Downs, Sina Tavakoli, and Reto Asmis, “Protein Thiol Redox Signaling in Monocytes and Macrophages,” Antioxidants & Redox Signaling, 2016. View at Publisher · View at Google Scholar
  • Stephanie Ragot, Vincent Rigalleau, Ronan Roussel, Pierre-Jean Saulnier, Elise Gand, Yousri Slaoui, Louis Potier, Philippe Zaoui, Frederic Fumeron, Michel Marre, Samy Hadjadj, Gilberto Velho, Astrid De Hauteclocque, Philippe Sosner, and Jean-Michel Halimi, “Dynamic changes in renal function are associated with major cardiovascular events in patients with type 2 diabetes,” Diabetes Care, vol. 39, no. 7, pp. 1259–1266, 2016. View at Publisher · View at Google Scholar
  • Maria Vanessa Perez-Gomez, Maria Dolores Sanchez-Niño, Ana Belen Sanz, Binbin Zheng, Catalina Martín-Cleary, Marta Ruiz-Ortega, Alberto Ortiz, and Beatriz Fernandez-Fernandez, “Targeting inflammation in diabetic kidney disease: early clinical trials,” Expert Opinion on Investigational Drugs, pp. 1–14, 2016. View at Publisher · View at Google Scholar
  • Manuela Borges Sangoi, José Antonio M. de Carvalho, Etiane Tatsch, Bruna S. Hausen, Yãnaí S. Bollick, Sílvia W.K. Londero, Thiago Duarte, Rogério Scolari, Marta M.M.F. Duarte, Melissa O. Premaor, Fabio V. Comim, Maria B. Moretto, and Rafael N. Moresco, “Urinary inflammatory cytokines as indicators of kidney damage in type 2 diabetic patients,” Clinica Chimica Acta, 2016. View at Publisher · View at Google Scholar
  • Yara A. Samra, Heba S. Said, Nehal M. Elsherbiny, Gregory I. Liou, Mamdouh M. El-Shishtawy, and Laila A. Eissa, “Cepharanthine and Piperine ameliorate diabetic nephropathy in rats: role of NF-κB and NLRP3 inflammasome,” Life Sciences, 2016. View at Publisher · View at Google Scholar
  • Yu Sun Jung, and Hyeon Cheol Shin, “The Effects of Lycii Radicis Cortex on Inflammatory Response through an Oxidative Stress and AGEs-mediated Pathway in STZ-induced Diabetic Rats,” Journal of Korean Medicine, vol. 37, no. 2, pp. 62–75, 2016. View at Publisher · View at Google Scholar
  • Yan Sun, Rui Peng, Huimin Peng, Handeng Liu, Li Wen, Tianhui Wu, Hong Yi, Ailing Li, and Zheng Zhang, “miR-451 suppresses the NF-kappaB-mediated proinflammatory molecules expression through inhibiting LMP7 in diabetic nephropathy,” Molecular and Cellular Endocrinology, 2016. View at Publisher · View at Google Scholar
  • Cuneyt Kahraman, Nilufer Kuzeyli Kahraman, Bekir Aras, Suleyman Cosgun, and Erim Gulcan, “The relationship between neutrophil-to-lymphocyte ratio and albuminuria in type 2 diabetic patients: a pilot study,” Archives Of Medical Science, vol. 12, no. 3, pp. 571–575, 2016. View at Publisher · View at Google Scholar
  • Nehal M. Elsherbiny, and Mohammed M.H. Al-Gayyar, “The role of IL-18 in type 1 diabetic nephropathy: The problem and future treatment,” Cytokine, vol. 81, pp. 15–22, 2016. View at Publisher · View at Google Scholar
  • L. Lattenist, P. Ochodnický, M. Ahdi, N. Claessen, J. C. Leemans, S. C. Satchell, S. Florquin, V. E. Gerdes, and J. J. T. H. Roelofs, “Renal endothelial protein C receptor expression and shedding during diabetic nephropathy,” Journal of Thrombosis and Haemostasis, vol. 14, no. 6, pp. 1171–1182, 2016. View at Publisher · View at Google Scholar
  • Yingjie Xu, Quanbin Zhang, Dali Luo, Jing Wang, and Delin Duan, “Low molecular weight fucoidan modulates P-selectin and alleviates diabetic nephropathy,” International Journal of Biological Macromolecules, 2016. View at Publisher · View at Google Scholar
  • Pragasam Viswanathan, and Durairaj Vaishnudevi, “Seaweed polysaccharides - new therapeutic insights against the inflammatory response in diabetic nephropathy,” Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry, vol. 15, no. 3, pp. 178–190, 2016. View at Publisher · View at Google Scholar
  • Kultigin Turkmen, “Inflammation, oxidative stress, apoptosis, and autophagy in diabetes mellitus and diabetic kidney disease: the Four Horsemen of the Apocalypse,” International Urology and Nephrology, 2016. View at Publisher · View at Google Scholar
  • La Zhang, Lei Zhang, Yin Li, Xin-feng Guo, and Xu-sheng Liu, “Biotransformation effect of Bombyx Mori L. may play an important role in treating diabetic nephropathy,” Chinese Journal of Integrative Medicine, vol. 22, no. 11, pp. 872–879, 2016. View at Publisher · View at Google Scholar
  • Tzer-Min Kuo, Hui-Ting Hsu, Chia-Min Chung, Kun-Tu Yeh, Cheng-Tien Wu, Chi-Pin Lee, Shang-Lun Chiang, Chung-Ming Huang, and Ying-Chin Ko, “Enhanced alpha-kinase 1 accelerates multiple early nephropathies in streptozotocin-induced hyperglycemic mice,” Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol. 1862, no. 11, pp. 2034–2042, 2016. View at Publisher · View at Google Scholar
  • Ralph D. Sanderson, Michael Elkin, Alan C. Rapraeger, Neta Ilan, and Israel Vlodavsky, “Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy,” The FEBS Journal, vol. 284, no. 1, pp. 42–55, 2016. View at Publisher · View at Google Scholar
  • Anwar D. Maraqa, “Effect of atorvastatin on interleukins and prostaglandin E2 in the kidney of type 1 diabetic rats,” European Cytokine Network, vol. 27, no. 4, pp. 97–101, 2016. View at Publisher · View at Google Scholar
  • Lin Sun, Fayyaz S. Sutterwala, Yinghong Liu, Weizhou Zhang, Fang Yuan, Ryan Kolb, Gaurav Pandey, Wei Li, and Fuyou Liu, “Involvement of the NLRC4-inflammasome in diabetic nephropathy,” PLoS ONE, vol. 11, no. 10, 2016. View at Publisher · View at Google Scholar
  • TingTing Zhao, SiFan Sun, HaoJun Zhang, XiaoRu Huang, MeiHua Yan, Xi Dong, YuMin Wen, Hua Wang, Hui Yao Lan, and Ping Li, “Therapeutic Effects of Tangshen Formula on Diabetic Nephropathy in Rats,” Plos One, vol. 11, no. 1, 2016. View at Publisher · View at Google Scholar
  • Serap Sancar-Bas, Selda Gezginci-Oktayoglu, and Sehnaz Bolkent, “Exendin-4 attenuates renal tubular injury by decreasing oxidative stress and inflammation in streptozotocin-induced diabetic mice,” Growth Factors, pp. 1–11, 2016. View at Publisher · View at Google Scholar
  • Samah M. Fathy, and Ehab A. Drees, “Protective effects of Egyptian cloudy apple juice and apple peel extract on lipid peroxidation, antioxidant enzymes and inflammatory status in diabetic rat pancreas,” BMC Complementary and Alternative Medicine, vol. 16, no. 1, 2016. View at Publisher · View at Google Scholar
  • Hung-Wen Liu, Chu-Chun Wei, and Sue-Joan Chang, “Low-molecular-weight polyphenols protect kidney damage through suppressing NF-κB and modulating mitochondrial biogenesis in diabetic db/db mice,” Food Funct., 2016. View at Publisher · View at Google Scholar
  • Cüneyt Kahraman, Nilufer Kuzeyli Kahraman, and Süleyman Cosgun, “Prognostic value of the monocyte/high density lipoprotein cholesterol ratio in diabetic nephropathy patients,” Acta Medica Mediterranea, vol. 32, no. 4, pp. 981–985, 2016. View at Publisher · View at Google Scholar
  • Jian-xia Shi, Qi-jin Wang, Hui Li, and Qin Huang, “Silencing of USP22 suppresses high glucose-induced apoptosis, ROS production and inflammation in podocytes,” Mol. BioSyst., 2016. View at Publisher · View at Google Scholar
  • Shirong Zheng, Susan Coventry, Lu Cai, David W. Powell, Venkatakrishna R. Jala, Bodduluri Haribabu, and Paul N. Epstein, “Renal Protection by Genetic Deletion of the Atypical Chemokine Receptor ACKR2 in Diabetic OVE Mice,” Journal of Diabetes Research, vol. 2016, pp. 1–11, 2016. View at Publisher · View at Google Scholar
  • Rudolf Flückiger, Enzo Cocuzzi, Ram H. Nagaraj, Menachem Shoham, Timothy S. Kern, and M. Edward Medof, “DAF in diabetic patients is subject to glycation/inactivation at its active site residues,” Molecular Immunology, 2017. View at Publisher · View at Google Scholar
  • Gandhipuram Periyasamy Senthilkumar, Melepallappil Sabeenakumari Anithalekshmi, Md. Yasir, Sreejith Parameswaran, Rajaa muthu Packirisamy, and Zachariah Bobby, “Role of omentin 1 and IL-6 in type 2 diabetes mellitus patients with diabetic nephropathy,” Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2017. View at Publisher · View at Google Scholar
  • Gui-Lian Ni, Rong Cui, Ai-Min Shao, and Zhong-Min Wu, “Salidroside Ameliorates Diabetic Neuropathic Pain in Rats by Inhibiting Neuroinflammation,” Journal of Molecular Neuroscience, 2017. View at Publisher · View at Google Scholar
  • Kevin M Wheelock, Pierre-Jean Saulnier, Stephanie K Tanamas, Pavithra Vijayakumar, E Jennifer Weil, Helen C Looker, Robert L Hanson, Kevin V Lemley, Berne Yee, William C Knowler, Samy Hadjadj, Behzad Najafian, Michael Mauer, and Robert G Nelson, “White blood cell fractions correlate with lesions of diabetic kidney disease and predict loss of kidney function in Type 2 diabetes,” Nephrology Dialysis Transplantation, vol. 33, no. 6, pp. 1001–1009, 2017. View at Publisher · View at Google Scholar
  • Jian Wu, Xiaohong Shao, Kan Lu, Miaomiao Ren, Xiaoyu Shen, Chunling Zhu, Jing Zhou, Xin Xie, Jibo Liu, Yi Xu, and Yaqin Ding, “Urinary RBP and NGAL Levels are Associated with Nephropathy in Patients with Type 2 Diabetes,” Cellular Physiology and Biochemistry, vol. 42, no. 2, pp. 594–602, 2017. View at Publisher · View at Google Scholar
  • Eun Soo Lee, You Mi Kim, Mi Young Lee, Mi-Hye Kwon, Hong Min Kim, Jeong Suk Kang, Eun Young Lee, and Choon Hee Chung, “Sarpogrelate hydrochloride ameliorates diabetic nephropathy associated with inhibition of macrophage activity and inflammatory reaction in db/db mice,” PLoS ONE, vol. 12, no. 6, 2017. View at Publisher · View at Google Scholar
  • Nooshin Mohammadzadeh, Soghra Mehri, and Hossein Hosseinzadeh, “Berberis vulgaris and its constituent berberine as antidotes and protective agents against natural or chemical toxicities,” Iranian Journal of Basic Medical Sciences, vol. 20, no. 5, pp. 538–551, 2017. View at Publisher · View at Google Scholar
  • Sagar Ashokrao Khandare, Sachin Chittawar, Nitin Nahar, Dubey, and Zahraan Qureshi, “Study of neutrophil-lymphocyte ratio as novel marker for diabetic nephropathy in type 2 diabetes,” Indian Journal of Endocrinology and Metabolism, vol. 21, no. 3, pp. 387–392, 2017. View at Publisher · View at Google Scholar
  • Jana M. Orellana, Kapil Kampe, Friederike Schulze, Jonas Sieber, and Andreas W. Jehle, “Fetuin-A aggravates lipotoxicity in podocytes via interleukin-1 signaling,” Physiological Reports, vol. 5, no. 10, 2017. View at Publisher · View at Google Scholar
  • Jin-Ni Hong, Wei-Wei Li, Lin-Lin Wang, Hao Guo, Yong Jiang, Yun-Jia Gao, Peng-Fei Tu, and Xue-Mei Wang, “Jiangtang decoction ameliorate diabetic nephropathy through the regulation of PI3K/Akt-mediated NF-κB pathways in KK-Ay mice,” Chinese Medicine, vol. 12, no. 1, 2017. View at Publisher · View at Google Scholar
  • Carole G. Campion, Oraly Sanchez-Ferras, and Sri N. Batchu, “Potential Role of Serum and Urinary Biomarkers in Diagnosis and Prognosis of Diabetic Nephropathy,” Canadian Journal of Kidney Health and Disease, vol. 4, pp. 205435811770537, 2017. View at Publisher · View at Google Scholar
  • Siying Liu, Hangping Zheng, Xiaoming Zhu, Fei Mao, Shuo Zhang, Hongli Shi, Yiming Li, and Bin Lu, “Neutrophil-to-lymphocyte ratio is associated with diabetic peripheral neuropathy in type 2 diabetes patients,” Diabetes Research and Clinical Practice, 2017. View at Publisher · View at Google Scholar
  • Xing-Xin Xu, Chao-Ran Liu, Yun-Xia Shao, Kun Wang, and Yong-Gui Wu, “Effect of paeoniflorin on TLR2/4 pathway in AGEs-induced RAW264.7 macrophages,” Chinese Pharmacological Bulletin, vol. 33, no. 5, pp. 675–680, 2017. View at Publisher · View at Google Scholar
  • Wei-Yu Chen, Lung-Chih Li, and Jenq-Lin Yang, “Emerging Roles of IL-33/ST2 Axis in Renal Diseases,” International Journal of Molecular Sciences, vol. 18, no. 4, pp. 783, 2017. View at Publisher · View at Google Scholar
  • Dilip Sharma, Pallab Bhattacharya, Kiran Kalia, and Vinod Tiwari, “Diabetic Nephropathy: New Insights into Established Therapeutic Paradigms and Novel Molecular Targets,” Diabetes Research and Clinical Practice, 2017. View at Publisher · View at Google Scholar
  • Hong Seok Kim, and Reto Asmis, “Mitogen-activated protein kinase phosphatase 1 (MKP-1) in macrophage biology and cardiovascular disease. A redox-regulated master controller of monocyte function and macrophage phenotype,” Free Radical Biology and Medicine, 2017. View at Publisher · View at Google Scholar
  • Sachin Chittawar, Deep Dutta, Sagar Khandare, Tribhuvan Nath Dubey, Zahran Qureshi, and Vineet Surana, “Neutrophil-lymphocyte ratio is a novel reliable predictor of nephropathy, retinopathy, and coronary artery disease in Indians with type-2 diabetes,” Indian Journal of Endocrinology and Metabolism, vol. 21, no. 6, pp. 864–870, 2017. View at Publisher · View at Google Scholar
  • Christopher Kaul, Aditya Grover, and Yashwant Pathak, “The Role of Pro-Inflammatory Factors and Metabolic Stress in Disease,” Nutrigenomics and Nutraceuticals, pp. 217–226, 2017. View at Publisher · View at Google Scholar
  • Jing Yu, Zi-Yu Liu, Qi Zhu, Ke-Qin Zhang, Hao Wu, and Chang Shan, “Advanced glycation end products induce the apoptosis of and inflammation in mouse podocytes through CXCL9-mediated JAK2/STAT3 pathway activation,” International Journal of Molecular Medicine, vol. 40, no. 4, pp. 1185–1193, 2017. View at Publisher · View at Google Scholar
  • Fabiana Piovesan, Glaucia S. Tres, Leila B. Moreira, Michael E. Andrades, Hugo K. Lisboa, and Sandra C. Fuchs, “Effect of diacerein on renal function and inflammatory cytokines in participants with type 2 diabetes mellitus and chronic kidney disease: A randomized controlled trial,” Plos One, vol. 12, no. 10, pp. e0186554, 2017. View at Publisher · View at Google Scholar
  • Dhamodharan Umapathy, Krishnamoorthy Ezhilarasi, Vairamani Mariappanadar, Vijay Viswanathan, and Kunka Mohanram Ramkumar, “Increased levels of circulating (TNF-α) is associated with (-308G/A) promoter polymorphism of TNF-α gene in Diabetic Nephropathy,” International Journal of Biological Macromolecules, 2017. View at Publisher · View at Google Scholar
  • Xia Chen, Niansong Wang, Sheng Ge, Feng Wang, Rui Wu, Yiwei Kong, Yuting Yang, Yu Gao, Dandan Sun, Qizhen Liu, Dongjun Dai, and Zeyuan Lu, “Tanshinone II Aattenuates renal damage in STZ-induced diabetic rats via inhibiting oxidative stress and inflammation,” Oncotarget, vol. 8, no. 19, pp. 31915–31922, 2017. View at Publisher · View at Google Scholar
  • Suxia Yang, Junwei Zhang, Shiying Wang, Xinxin Zhao, and Jun Shi, “SOCS2 overexpression alleviates diabetic nephropathy in rats by inhibiting the TLR4/NF-κB pathway,” Oncotarget, vol. 8, no. 53, pp. 91185–91198, 2017. View at Publisher · View at Google Scholar
  • Jie Lv, Zhen Wang, Ying Wang, Weiwei Sun, Jingwei Zhou, Mengdi Wang, Wei Jing Liu, and Yaoxian Wang, “ Renoprotective Effect of the Shen-Yan-Fang-Shuai Formula by Inhibiting TNF- α /NF- κ B Signaling Pathway in Diabetic Rats ,” Journal of Diabetes Research, vol. 2017, pp. 1–11, 2017. View at Publisher · View at Google Scholar
  • Selim Fakhruddin, Wael Alanazi, and Keith E. Jackson, “Diabetes-Induced Reactive Oxygen Species: Mechanism of Their Generation and Role in Renal Injury,” Journal of Diabetes Research, vol. 2017, pp. 1–30, 2017. View at Publisher · View at Google Scholar
  • Xiaoling Wang, Lu Fan, Hua Zuo, Zhubo Li, Dejuan Li, and Qianhan Xiao, “CAPE-pNO2 ameliorated diabetic nephropathy through regulating the Akt/NF-κB/ iNOS pathway in STZ-induced diabetic mice,” Oncotarget, vol. 8, no. 70, pp. 114506–114525, 2017. View at Publisher · View at Google Scholar
  • Yan Hong, Jianyun Peng, Xiaoping Cai, Xiaoru Zhang, Yifei Liao, and Lejian Lan, “Clinical Efficacy of Alprostadil Combined with α-lipoic Acid in the Treatment of Elderly Patients with Diabetic Nephropathy.,” Open medicine (Warsaw, Poland), vol. 12, pp. 323–327, 2017. View at Publisher · View at Google Scholar
  • Greg H. Tesch, “Diabetic nephropathy - is this an immune disorder?,” Clinical Science, vol. 131, no. 16, pp. 2183–2199, 2017. View at Publisher · View at Google Scholar
  • Nawal M. Al-Rasheed, Nouf M. Al-Rasheed, Yieldez A. Bassiouni, Iman H. Hasan, Maha A. Al-Amin, Hanaa N. Al-Ajmi, and Ayman M. Mahmoud, “Simvastatin ameliorates diabetic nephropathy by attenuating oxidative stress and apoptosis in a rat model of streptozotocin-induced type 1 diabetes,” Biomedicine & Pharmacotherapy, vol. 105, pp. 290–298, 2018. View at Publisher · View at Google Scholar
  • Jun Jiang, Jiangning Yin, Xiang Liu, Huajun Wang, and Guoyuan Lu, “Erzhi Formula Extracts Reverse Renal Injury in Diabetic Nephropathy Rats by Protecting the Renal Podocytes,” Evidence-Based Complementary and Alternative Medicine, vol. 2018, pp. 1–13, 2018. View at Publisher · View at Google Scholar
  • Habib Yaribeygi, Alexandra E. Butler, Stephen L. Atkin, Niki Katsiki, and Amirhossein Sahebkar, “Sodium-glucose cotransporter 2 inhibitors and inflammation in chronic kidney disease: Possible molecular pathways,” Journal of Cellular Physiology, 2018. View at Publisher · View at Google Scholar
  • Jiandong Lu, Jinting Peng, Min Xiang, Liangping He, Dongcai Wang, Guoliang Xiong, and Shunmin Li, “ Trichosanthes kirilowii lectin alleviates diabetic nephropathy by inhibiting the LOX1/NF-κB/caspase-9 signaling pathway ,” Bioscience Reports, vol. 38, no. 5, pp. BSR20180071, 2018. View at Publisher · View at Google Scholar
  • Ellen Berni, Nicholas Pritchard, Sara Jenkins-Jones, Philip Ambery, Meena Jain, Lutz Jermutus, Laura A. Scott, and Craig J. Currie, “Hospital admissions for severe infections in people with chronic kidney disease in relation to renal disease severity and diabetes status,” Endocrinology, Diabetes & Metabolism, pp. e00029, 2018. View at Publisher · View at Google Scholar
  • Ali F. Abdel-Wahab, Ghazi A. Bamagous, Randa M. Al-Harizy, Naser A. ElSawy, Naiyer Shahzad, Ibrahim A. Ibrahim, and Saeed S. Al Ghamdi, “Renal protective effect of SGLT2 inhibitor dapagliflozin alone and in combination with irbesartan in a rat model of diabetic nephropathy,” Biomedicine & Pharmacotherapy, vol. 103, pp. 59–66, 2018. View at Publisher · View at Google Scholar
  • Yezi Zou, Zhiquan Chen, Jie Li, Wenyan Gong, Lei Zhang, Futian Xu, Lihao Chen, Peiqing Liu, and Heqing Huang, “Progestin and AdipoQ Receptor 3 Upregulates Fibronectin and Intercellular Adhesion Molecule-1 in Glomerular Mesangial Cells via Activating NF-κB Signaling Pathway Under High Glucose Conditions,” Frontiers in Endocrinology, vol. 9, 2018. View at Publisher · View at Google Scholar
  • Opeyemi Joshua Olatunji, Hongxia Chen, and Yifeng Zhou, “Lycium chinense leaves extract ameliorates diabetic nephropathy by suppressing hyperglycemia mediated renal oxidative stress and inflammation,” Biomedicine & Pharmacotherapy, vol. 102, pp. 1145–1151, 2018. View at Publisher · View at Google Scholar
  • Chin-Hua Chang, Chew-Teng Kor, Chia-Lin Wu, Ping-Fang Chiu, Jhao-Rong Li, Chun-Chieh Tsai, Teng-Hsiang Chang, and Chia-Chu Chang, “Increased chronic kidney disease development and progression in diabetic patients after appendectomy: a population-based cohort study,” PeerJ, vol. 6, pp. e5019, 2018. View at Publisher · View at Google Scholar
  • Martina Gáliková, and Peter Klepsatel, “Obesity and Aging in the Drosophila Model,” International Journal of Molecular Sciences, vol. 19, no. 7, pp. 1896, 2018. View at Publisher · View at Google Scholar
  • Habib Yaribeygi, Mohammad T. Mohammadi, Ramin Rezaee, and Amirhossein Sahebkar, “Fenofibrate improves renal function by amelioration of NOX-4, IL-18, and p53 expression in an experimental model of diabetic nephropathy,” Journal of Cellular Biochemistry, 2018. View at Publisher · View at Google Scholar
  • Bubuya Masola, Oluwafemi O. Oguntibeju, and Ayodeji B. Oyenihi, “Centella asiatica ameliorates diabetes-induced stress in rat tissues via influences on antioxidants and inflammatory cytokines,” Biomedicine & Pharmacotherapy, vol. 101, pp. 447–457, 2018. View at Publisher · View at Google Scholar
  • James C. Harms, Cheng Jack Song, and Michal Mrug, “The Role of Inflammation and Fibrosis in Cystic Kidney Disease,” Polycystic Kidney Disease, pp. 111–129, 2018. View at Publisher · View at Google Scholar
  • Helen C. Looker, Michael Mauer, and Robert G. Nelson, “Role of Kidney Biopsies for Biomarker Discovery in Diabetic Kidney Disease,” Advances in Chronic Kidney Disease, vol. 25, no. 2, pp. 192–201, 2018. View at Publisher · View at Google Scholar
  • Eun Soo Lee, Hong Min Kim, Patchareewan Pannangpetch, Eun Young Lee, Choon Hee Chung, Upa Kukongviriyapan, Supawan Thawornchinsombut, Kampeebhorn Boonloh, Veerapol Kukongviriyapan, Mi Hye Kwon, You Mi Kim, and Bunkerd Kongyingyoes, “Rice bran protein hydrolysates attenuate diabetic nephropathy in diabetic animal model,” European Journal of Nutrition, vol. 57, no. 2, pp. 761–772, 2018. View at Publisher · View at Google Scholar
  • Whaseon Lee-Kwon, Braxton D. Mitchell, Hyug Moo Kwon, Sun Woo Lim, Eun Jin Yoo, Hwan Hee Lee, Satoru Sanada, Soo Youn Choi, Afshin Parsa, Shabnam Salimi, and Jun Ho Lee, “Tonicity-Responsive Enhancer-Binding Protein Mediates Hyperglycemia-Induced Inflammation and Vascular and Renal Injury,” Journal of the American Society of Nephrology, vol. 29, no. 2, pp. 492–504, 2018. View at Publisher · View at Google Scholar
  • Richard Van Krieken, Mandeep Marway, Pavithra Parthasarathy, Neel Mehta, Alistar J Ingram, Bo Gao, and Joan C Krepinsky, “Inhibition of SREBP With Fatostatin Does Not Attenuate Early Diabetic Nephropathy in Male Mice,” Endocrinology, vol. 159, no. 3, pp. 1479–1495, 2018. View at Publisher · View at Google Scholar
  • Jushuang Li, Liping Bao, Dongqing Zha, Lian Zhang, Ping Gao, Juan Zhang, and Xiaoyan Wu, “Oridonin protects against the inflammatory response in diabetic nephropathy by inhibiting the TLR4/p38-MAPK and TLR4/NF-κB signaling pathways,” International Immunopharmacology, vol. 55, pp. 9–19, 2018. View at Publisher · View at Google Scholar
  • Peipei Luan, Jianhui Zhuang, Jun Zou, Hailing Li, Ping Shuai, Xiaopeng Xu, Yifan Zhao, Wenxin Kou, Shuya Ji, Ai Peng, Yawei Xu, Qing Su, Weixia Jian, and Wenhui Peng, “NLRC5 deficiency ameliorates diabetic nephropathy through alleviating inflammation,” The FASEB Journal, vol. 32, no. 2, pp. 1070–1084, 2018. View at Publisher · View at Google Scholar
  • Yang Yuan, Tianying Zhang, Bo Xu, Tianjun Guan, Ping Chen, and Qing Gao, “Pentosan polysulfate ameliorates apoptosis and inflammation by suppressing activation of the p38 MAPK pathway in high glucose-treated HK-2 cells,” International Journal of Molecular Medicine, vol. 41, no. 2, pp. 908–914, 2018. View at Publisher · View at Google Scholar
  • Amir M. Al Hroob, Mohammad H. Abukhalil, Reham D. Alghonmeen, and Ayman M. Mahmoud, “Ginger alleviates hyperglycemia-induced oxidative stress, inflammation and apoptosis and protects rats against diabetic nephropathy,” Biomedicine & Pharmacotherapy, vol. 106, pp. 381–389, 2018. View at Publisher · View at Google Scholar
  • Yu Zhao, Yinfeng Guo, Yuteng Jiang, Xiaodong Zhu, and Xiaoliang Zhang, “Vitamin D suppresses macrophage infiltration by down-regulation of TREM-1 in diabetic nephropathy rats,” Molecular and Cellular Endocrinology, 2018. View at Publisher · View at Google Scholar
  • Maliha A Alikhan, Megan Huynh, A Richard Kitching, and Joshua D Ooi, “Regulatory T cells in renal disease,” Clinical & Translational Immunology, vol. 7, no. 1, pp. e1004, 2018. View at Publisher · View at Google Scholar
  • Sharad Purohit, Ashok Sharma, Wenbo Zhi, Shan Bai, Diane Hopkins, Leigh Steed, Bruce Bode, Stephen W. Anderson, John Chip Reed, R. Dennis Steed, and Jin-Xiong She, “Proteins of TNF-α and IL6 Pathways Are Elevated in Serum of Type-1 Diabetes Patients with Microalbuminuria,” Frontiers in Immunology, vol. 9, 2018. View at Publisher · View at Google Scholar